Skip to main content
 

Former EBM I Literature Review Requirements: Endocrinology Topics

This guide has information about the literature review assignment for the Evidence Based Medicine I course at NEOMED.

Diabetes

  •  Comparing metformin and glyburide in a combination medication as well as monotherapy in the treatment of diabetes mellitus type II
  • Comparing exenatide versus insulin glargine in the treatment of diabetes mellitus type II
  • Comparing insulin glulisine vs. insulin lispro for treating type II diabetes
  • Rosiglitazone vs. pioglitazone for treating type II diabetes
  • Rosiglitazone vs. pioglitazone for diabetic patients at risk for coronary heart disease
  • Rosiglitazone vs. insulin for diabetic patients at risk for coronary heart disease
  • Pioglitazone vs. insulin for diabetic patients at risk for coronary heart disease
  • Liraglutide vs. glimepiride to treat type II diabetes
  • Metformin vs. Actos for treating diabetes
  • Comparing liraglutide to exenatide for treating type II diabetes
  • Diet and exercise versus pioglitazone for treating obesity
  • Insulin glulisine vs. insulin lispro for treating diabetes
  • Comparing metformin to sulfonylureas: cardiovascular and all-cause mortality
  • Metformin and glimepiride vs. metformin and empagliflozin for treating type 2 diabetes
  • Exenatide vs. glimepiride for treating type 2 diabetes
  • Vildagliptin versus metformin for treating type 2 diabetes

Osteoporosis

  • Alendronate vs. risedronate for treating osteoporosis
  • Teriparatide and denosumab versus teriparatide alone for treating osteoporosis
  • Teriparatide and denosumab versus denosumab alone for treating osteoporosis
  • Ibandronate versus risedronate  for treating osteoporosis
  • Romosozumab versus alendronate for preventing fractures in women with osteoporosis
  • Ibandronate versus alendronate  for treating osteoporosis